Precision BioSciences Prices $125 Million Stock and Pre-Funded Warrant Offering

PUBT · 5d ago
Precision BioSciences Prices $125 Million Stock and Pre-Funded Warrant Offering
  • Precision BioSciences priced an underwritten offering of common stock and pre-funded warrants to raise approximately $125 million in gross proceeds.
  • The offering includes 10,235,077 common shares at $7.75 per share.
  • Pre-funded warrants to purchase up to 5,893,964 common shares were priced at $7.749995 each.
  • Closing is expected on or about November 6, 2026, subject to customary conditions.
  • Net proceeds will fund PBGENE-HBV and PBGENE-DMD research and development, working capital and general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precision BioSciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611050710BIZWIRE_USPR_____20261104_BW579338) on November 05, 2026, and is solely responsible for the information contained therein.